project id: TCGA-SKCM; case submitter id: TCGA-BF-A5ES; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 8.2; age at index: 76; days to birth: -28092; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 28092; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 490.0; icd 10 code: C44.5; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin of trunk; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 89; initial weight: 160.0; sample id: caf1bbfa-d165-482b-8169-8ea0cc00fa3d; sample submitter id: TCGA-BF-A5ES-01A; portion id: 7bbbac1b-13ae-4267-9663-57f4c62a1452; portion submitter id: TCGA-BF-A5ES-01A-11; slide id: ce4ee5c8-36c6-403b-9632-108ff906dc27; slide submitter id: TCGA-BF-A5ES-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 1.0; percent tumor cells: 99.0; percent tumor nuclei: 96.0; section location: TOP;